{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:18:06Z","timestamp":1792412286945,"version":"4.4.0"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system. Although the pathogenesis of MS is not yet fully elucidated, several evidences suggest that autoimmune processes mediated by Th1, Th17, and B cells play an important role in the development of the disease. Similar to other cells, immune cells need continuous access to amino acids (AA) in order to maintain basal metabolism and maintain vitality. When immune cells are activated by inflammation or antigenic signals, their demand for AA increases rapidly. Although AA deprivation itself may weaken the immune response under certain conditions, cells also have AA sensitive pathways that can activate intense alterations in cell metabolism based on changes in AA levels. Several data indicate that cells expressing enzymes that can degrade AA can regulate the functions of antigen-presenting cells and lymphocytes, revealing that the AA pathways are essential for controlling the function, and survival of immune cells, as well as immune cell gene expression. Basal AA catabolism may contribute to immune homeostasis and prevent autoimmunity, while increased AA catalytic activity may enhance immune suppression. In addition, there is increasing evidence that some downstream AA metabolites are important biological mediators of autoimmune response regulation. Two of the most important AA that modulate the immune response are L-Tryptophan (Trp) and L-Arginine (Arg). Tryptophan is catabolized through 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) 1 and IDO2 enzymes, while three other enzymes catabolize Arg: inducible nitric oxide synthetase (iNOS), and two arginase isoforms (ARG1, ARG2). Genes encoding IDO, iNOS and ARG are induced by inflammatory cues such as cytokines, a key feature that distinguishes them from enzymes that catabolize other AA. Evidence suggests that AA catabolism is decreased in MS patients and that this decrease has functional consequences, increasing pro-inflammatory cytokines and decreasing Treg cell numbers. These effects are mediated by at least two distinct pathways involving serine\/threonine kinases: the general control nonderepressible 2 kinase (GCN2K) pathway; and the mammalian target of rapamycin (mTOR) pathway. Similarly, IDO1-deficient mice showed exacerbation of experimental autoimmune encephalomyelitis (EAE), increased Th1 and Th17 cells, and decreased Treg cells. On the contrary, the administration of downstream Trp metabolite 3-HAA, inhibits Th1\/Th17 effector cells and promotes Treg response by up-regulating TGF-\u03b2 production by dendritic cells, thereby improving EAE. Collectively, these observations stand out the significance of AA catabolism in the regulation of the immune responses in MS patients. The molecules related to these pathways deserve further exploration as potential new therapeutic targets in MS<\/jats:p>","DOI":"10.3389\/fimmu.2020.600428","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T01:52:13Z","timestamp":1611107533000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Jorge","family":"Correale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29251","article-title":"Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis","volume":"116","author":"Astier","year":"2006","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of Multiple Sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120227","article-title":"Immunology of relapse and remission in multiple sclerosis","volume":"32","author":"Steinmann","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095956","article-title":"Metabolic regulation of T lymphocytes","volume":"31","author":"MacIver","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01149.x","article-title":"Amino acid catabolism: a pivotal regulator of innate and adaptive immunity","volume":"249","author":"McGaha","year":"2012","journal-title":"Immunol Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0135-0_21","article-title":"T cell apoptosis by kynurenines","volume":"527","author":"Fallarino","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001628","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01565","article-title":"Immunoregulatory Interplay Between Arginine and Tryptophan Metabolism in Health and Disease","volume":"10","author":"Mondanelli","year":"2019","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00915.x","article-title":"Control of immune response by amino acid metabolism","volume":"236","author":"Grohmann","year":"2010","journal-title":"Immunol Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1117634","article-title":"Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite","volume":"310","author":"Platten","year":"2005","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3030703","article-title":"The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity","volume":"3","author":"Mbongue","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat Rev Drug Discovery"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2003.10.006","article-title":"The kynurenine pathway of tryptophan degradation as a drug target","volume":"4","author":"Schwarcz","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.29.17247","article-title":"Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene","volume":"271","author":"Chon","year":"1996","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.32.19140","article-title":"Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene","volume":"271","author":"Konan","year":"1996","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/107999000312306","article-title":"Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently","volume":"20","author":"Currier","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/jir.2005.25.20","article-title":"The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase","volume":"25","author":"Robinson","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.9.5601","article-title":"Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling","volume":"175","author":"Mellor","year":"2005","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2008.11.006","article-title":"TGF-beta and kynurenines as the key to infectious tolerance","volume":"15","author":"Belladonna","year":"2009","journal-title":"Trends Mol Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903919106","article-title":"Infectious tolerance via the consuption of essential amino acids and mTOR signaling","volume":"106","author":"Cobbold","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365","article-title":"Elevation of oleate-activated phospholipase D activity during thymic atrophy","volume":"107","author":"Lee","year":"2002","journal-title":"Immunology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh271","article-title":"A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation","volume":"17","author":"Baban","year":"2005","journal-title":"Int Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Pallotta","year":"2011","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900986","article-title":"IDO activates regulatory T cells and blocks their conversion into Th17-like T cells","volume":"183","author":"Baban","year":"2009","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhamer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","article-title":"Regulation of the immune response by the Aryl Hydrocarbom Receptor","volume":"48","author":"Gutierez-Velasquez","year":"2018","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1124\/pr.113.007823","article-title":"Aryl hydrocarbon receptor controladaptative immunity","volume":"65","author":"Quintana","year":"2013","journal-title":"PharmacolRev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1351","article-title":"Tryptamine serves as a proligand of the AhR transcriptional pathway whose activation is dependent of monoamino oxidases","volume":"26","author":"Vikstr\u00f6m Bergnader","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.3.550","article-title":"Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor","volume":"64","author":"Bittinger","year":"2003","journal-title":"Mol Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1124\/mol113.091165","article-title":"Micorbiome-derived tryoptophamn metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities","volume":"85","author":"Jin","year":"2014","journal-title":"Mol Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.52.32824","article-title":"Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds","volume":"272","author":"Miller","year":"1997","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1021\/tx9004506","article-title":"3-methylindole metabolites induce lung CYPA1 and CYP2F1 enzymes by AhR and non-AhR mechanisms respectively","volume":"23","author":"Weems","year":"2010","journal-title":"Chem Res Toxicol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell mediated autoimmunity to environmental toxins","author":"Veldohen","year":"7191","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regualtory T-cell like and Fosp3 (+) regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/srep23820","article-title":"Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunity","volume":"6","author":"Chng","year":"2016","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.08.016","article-title":"Aryl Hydrocarbon Receptor controls monocyte differentiation into dendritic cells versus macrophages","volume":"47","author":"Goudon","year":"2017","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxu077","article-title":"Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3 dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation","volume":"26","author":"Eleftheriadis","year":"2014","journal-title":"Int Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3892\/ijimm.2018.3624","article-title":"IDO decreases glycolysis and gluteminolysis by activating GCN2K, while it icreases fatty acid oxidation by activating AhR tus preserving CD4+ T cell survival and proliferation","volume":"42","author":"Eleftheriadis","year":"2018","journal-title":"Int Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm2013.08.268","article-title":"Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte reaction affects glucose influx and enzymes involved in aerobic glycolysis and glutamynolisis in alloreactive T-cells","volume":"74","author":"Eleftheriadis","year":"2013","journal-title":"Hum Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/imm.12502","article-title":"Indoleamine 2,3 \u2013dioxygenase depletes tryoptophan, activates general control non-derepressible 2 kinase and down-regualtes key enzymes involved in fatty acid synthesis in primary CD4+ T cells","volume":"146","author":"Eleftheriadis","year":"2015","journal-title":"Immunology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.09036702567.2002.01532.x","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.40449\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3323","article-title":"Amino acid auxotrophy as a system of immunological control nodes","volume":"17","author":"Murray","year":"2016","journal-title":"Nat Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00291.x","article-title":"Arginase: an emerging key player in the mammalian immune system","volume":"158","author":"Munder","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1109737","article-title":"Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation","volume":"89","author":"Rotondo","year":"2011","journal-title":"J Leukoc Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110675200","article-title":"Regulation of T cell receptor CD3zeta chain expression by L-arginine","volume":"277","author":"Rodriguez","year":"2002","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001224","article-title":"L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression","volume":"185","author":"Rodriguez","year":"2010","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-031856","article-title":"Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.01.005","article-title":"A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells","volume":"46","author":"Mondanelli","year":"2017","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.6.1425","article-title":"The tRNA-binding moiety in GCN2 contains a dimerization domain that interacts with the kinase domain and is required for tRNA binding and kinase activation","volume":"20","author":"Qiu","year":"2001","journal-title":"EMBO J"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1021\/bi0008682","article-title":"Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha (P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B","volume":"39","author":"Sudhakar","year":"2000","journal-title":"Biochemistry"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.05.008","article-title":"ATF-4 dependent transcription mediates signaling of amino acid limitation","volume":"20","author":"Kilberg","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400541101","article-title":"Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells","volume":"101","author":"Vattem","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1813352116","article-title":"Activation of GCN2 by the ribosomal p-stalk","volume":"116","author":"Inglis","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2014.03.003","article-title":"Regulation of mTORC1 by amino acids","volume":"24","author":"Bar-Peled","year":"2014","journal-title":"Trends Cell Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20121098","article-title":"Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR","volume":"449","author":"Gallinetti","year":"2013","journal-title":"Biochem J"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.11.015","article-title":"Glutamine is a key regulator for amino-acid \u2013controlled cell growth through the mTOR signaling pathway in rat intestinal epithelial cells","volume":"326","author":"Nakajo","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.43.28178","article-title":"Branche-chain amino acids are essential in the regulation of PHAS-I and p70S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling","volume":"273","author":"Xu","year":"1998","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324455","article-title":"Activation requirements for the induction of CD4+CD25+ T cell suppressor function","volume":"34","author":"Thornton","year":"2004","journal-title":"Eur J Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31911","article-title":"Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase","volume":"117","author":"Sharma","year":"2007","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/science.1172638","article-title":"Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response","volume":"324","author":"Sundrud","year":"2009","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545886","article-title":"mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets","volume":"46","author":"Ren","year":"2016","journal-title":"Eur J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309986200","article-title":"Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1\/CIP1 promoter activity independent of p53","volume":"278","author":"Yu","year":"2003","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005.","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2867","article-title":"The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex","volume":"15","author":"Heikamp","year":"2014","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2217\/imt.14.84","article-title":"mTOR signaling, Tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12126","article-title":"Rapamycin unbalances the polarization of human macrophages to M1","volume":"140","author":"Mercalli","year":"2013","journal-title":"Immunology"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-3228fje","article-title":"Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation","volume":"19","author":"Kwidzinski","year":"2005","journal-title":"FASEB J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.02.011","article-title":"Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice","volume":"81","author":"Fazio","year":"2014","journal-title":"Neuropharmacology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nm.2183","article-title":"Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation","volume":"16","author":"Fallarino","year":"2010","journal-title":"Nat Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601139","article-title":"Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis","volume":"198","author":"Negrotto","year":"2017","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1918215117","article-title":"Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation","volume":"117","author":"Mondanelli","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2005.00442.x","article-title":"Kynurenine metabolism in multiple sclerosis","volume":"112","author":"Hartai","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci Lett"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-007-0667-y","article-title":"Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis","volume":"114","author":"Rejdak","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0130715","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis","volume":"10","author":"Mancuso","year":"2015","journal-title":"PloS One"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-016-9702-9","article-title":"Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis","volume":"11","author":"Wen","year":"2016","journal-title":"J Neuroimmune Pharmacol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912531107","article-title":"N-actylserotonin activates TrkB receptor in a circadian rhythm","volume":"107","author":"Jang","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1338.1352","DOI":"10.1016\/j.cell.2015.08.025","article-title":"Melatonin contributes to the seasonality of multiple sclerosis relapses","volume":"162","author":"Farez","year":"2015","journal-title":"Cell"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(00)00504-2","article-title":"Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis","volume":"102","author":"Chiarugi","year":"2001","journal-title":"Neuroscience"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10175","article-title":"Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes","volume":"41","author":"Guillemin","year":"2003","journal-title":"Glia"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401753","article-title":"Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model","volume":"4","author":"Fiala","year":"1998","journal-title":"Mol Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199701200-00011","article-title":"Activated human microglia produce the excitotoxin quinolinic acid","volume":"8","author":"Espey","year":"1997","journal-title":"Neuroreport"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0135-0_19","article-title":"Quinolinic acid in the pathogenesis of Alzheimer\u2019s disease","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666151215095940","article-title":"Triptophan metabolites and their impact in multiple sclerosis progression","volume":"22","author":"Watzlawik","year":"2016","journal-title":"Curr Pharmacol Des"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2174\/092986712800167365","article-title":"Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects","volume":"19","author":"Szalardy","year":"2012","journal-title":"Curr Med Chem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0204-5","article-title":"Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies","volume":"11","author":"Sundaram","year":"2014","journal-title":"J Neuroinflam"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577188","article-title":"Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis","volume":"342","author":"Lisak","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2174\/1568026611209061797","article-title":"Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction","volume":"12","author":"Szalardy","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/bph12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.05.043","article-title":"Glutaminolysis activates Rag-mTORC1 signaling","volume":"47","author":"Dur\u00e1n","year":"2012","journal-title":"Mol Cell"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901329","article-title":"Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells","volume":"183","author":"Zheng","year":"2009","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2556","article-title":"Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.600428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T01:52:17Z","timestamp":1611107537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.600428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":110,"alternative-id":["10.3389\/fimmu.2020.600428"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.600428","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"article-number":"600428"}}